First Header Logo Second Header Logo

Connection

Dawen Zhao to Animals

Back to Details
This is a "connection" page, showing publications Dawen Zhao has written about Animals.
Dawen Zhao
Connection Strength
1.355
Animals
  1. Arledge CA, Sankepalle DM, Crowe WN, Liu Y, Wang L, Zhao D. Deep learning quantification of vascular pharmacokinetic parameters in mouse brain tumor models. Front Biosci (Landmark Ed). 2022 03 16; 27(3):99.
    View in: PubMed
    Score: 0.092
  2. Liu Y, Crowe WN, Wang L, Lu Y, Petty WJ, Habib AA, Zhao D. An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases. Nat Commun. 2019 11 08; 10(1):5108.
    View in: PubMed
    Score: 0.078
  3. Crowe W, Wang L, Zhang Z, Varagic J, Bourland JD, Chan MD, Habib AA, Zhao D. MRI evaluation of the effects of whole brain radiotherapy on breast cancer brain metastasis. Int J Radiat Biol. 2019 03; 95(3):338-346.
    View in: PubMed
    Score: 0.073
  4. Wang L, Habib AA, Mintz A, Li KC, Zhao D. Phosphatidylserine-Targeted Nanotheranostics for Brain Tumor Imaging and Therapeutic Potential. Mol Imaging. 2017 01 01; 16:1536012117708722.
    View in: PubMed
    Score: 0.064
  5. Zhang L, Habib AA, Zhao D. Phosphatidylserine-targeted liposome for enhanced glioma-selective imaging. Oncotarget. 2016 Jun 21; 7(25):38693-38706.
    View in: PubMed
    Score: 0.062
  6. Zhao D, Pacheco-Torres J, Hallac RR, White D, Peschke P, Cerdán S, Mason RP. Dynamic oxygen challenge evaluated by NMR T1 and T2*--insights into tumor oxygenation. NMR Biomed. 2015 Aug; 28(8):937-947.
    View in: PubMed
    Score: 0.057
  7. Zhang L, Zhao D. Applications of nanoparticles for brain cancer imaging and therapy. J Biomed Nanotechnol. 2014 Sep; 10(9):1713-31.
    View in: PubMed
    Score: 0.054
  8. Zhou H, Stafford JH, Hallac RR, Zhang L, Huang G, Mason RP, Gao J, Thorpe PE, Zhao D. Phosphatidylserine-targeted molecular imaging of tumor vasculature by magnetic resonance imaging. J Biomed Nanotechnol. 2014 May; 10(5):846-55.
    View in: PubMed
    Score: 0.053
  9. Zhang L, Zhou H, Belzile O, Thorpe P, Zhao D. Phosphatidylserine-targeted bimodal liposomal nanoparticles for in vivo imaging of breast cancer in mice. J Control Release. 2014 Jun 10; 183:114-23.
    View in: PubMed
    Score: 0.053
  10. Zhou H, Zhao D. Ultrasound imaging-guided intracardiac injection to develop a mouse model of breast cancer brain metastases followed by longitudinal MRI. J Vis Exp. 2014 Mar 06; (85).
    View in: PubMed
    Score: 0.053
  11. Zhang L, Zhao D. Liposomal encapsulation enhances in vivo near infrared imaging of exposed phosphatidylserine in a mouse glioma model. Molecules. 2013 Nov 26; 18(12):14613-28.
    View in: PubMed
    Score: 0.052
  12. Zhou H, Chen M, Zhao D. Longitudinal MRI evaluation of intracranial development and vascular characteristics of breast cancer brain metastases in a mouse model. PLoS One. 2013; 8(4):e62238.
    View in: PubMed
    Score: 0.050
  13. Saha D, Dunn H, Zhou H, Harada H, Hiraoka M, Mason RP, Zhao D. In vivo bioluminescence imaging of tumor hypoxia dynamics of breast cancer brain metastasis in a mouse model. J Vis Exp. 2011 Oct 03; (56).
    View in: PubMed
    Score: 0.044
  14. Zhao D, Chang CH, Kim JG, Liu H, Mason RP. In vivo near-infrared spectroscopy and magnetic resonance imaging monitoring of tumor response to combretastatin A-4-phosphate correlated with therapeutic outcome. Int J Radiat Oncol Biol Phys. 2011 Jun 01; 80(2):574-81.
    View in: PubMed
    Score: 0.043
  15. Zhou H, Luby-Phelps K, Mickey BE, Habib AA, Mason RP, Zhao D. Dynamic near-infrared optical imaging of 2-deoxyglucose uptake by intracranial glioma of athymic mice. PLoS One. 2009 Nov 30; 4(11):e8051.
    View in: PubMed
    Score: 0.039
  16. Zhao D, Jiang L, Hahn EW, Mason RP. Comparison of 1H blood oxygen level-dependent (BOLD) and 19F MRI to investigate tumor oxygenation. Magn Reson Med. 2009 Aug; 62(2):357-64.
    View in: PubMed
    Score: 0.038
  17. Zhao D, Richer E, Antich PP, Mason RP. Antivascular effects of combretastatin A4 phosphate in breast cancer xenograft assessed using dynamic bioluminescence imaging and confirmed by MRI. FASEB J. 2008 Jul; 22(7):2445-51.
    View in: PubMed
    Score: 0.034
  18. Zhao D, Jiang L, Hahn EW, Mason RP. Tumor physiologic response to combretastatin A4 phosphate assessed by MRI. Int J Radiat Oncol Biol Phys. 2005 Jul 01; 62(3):872-80.
    View in: PubMed
    Score: 0.029
  19. Zhao D, Jiang L, Hahn EW, Mason RP. Continuous low-dose (metronomic) chemotherapy on rat prostate tumors evaluated using MRI in vivo and comparison with histology. Neoplasia. 2005 Jul; 7(7):678-87.
    View in: PubMed
    Score: 0.029
  20. Zhao D, Jiang L, Mason RP. Measuring changes in tumor oxygenation. Methods Enzymol. 2004; 386:378-418.
    View in: PubMed
    Score: 0.026
  21. Zhao D, Ran S, Constantinescu A, Hahn EW, Mason RP. Tumor oxygen dynamics: correlation of in vivo MRI with histological findings. Neoplasia. 2003 Jul-Aug; 5(4):308-18.
    View in: PubMed
    Score: 0.025
  22. Zhao D, Constantinescu A, Chang CH, Hahn EW, Mason RP. Correlation of tumor oxygen dynamics with radiation response of the dunning prostate R3327-HI tumor. Radiat Res. 2003 May; 159(5):621-31.
    View in: PubMed
    Score: 0.025
  23. Zhao D, Constantinescu A, Hahn EW, Mason RP. Differential oxygen dynamics in two diverse Dunning prostate R3327 rat tumor sublines (MAT-Lu and HI) with respect to growth and respiratory challenge. Int J Radiat Oncol Biol Phys. 2002 Jul 01; 53(3):744-56.
    View in: PubMed
    Score: 0.023
  24. Zhao D, Constantinescu A, Hahn EW, Mason RP. Tumor oxygen dynamics with respect to growth and respiratory challenge: investigation of the Dunning prostate R3327-HI tumor. Radiat Res. 2001 Nov; 156(5 Pt 1):510-20.
    View in: PubMed
    Score: 0.022
  25. Zhao D, Constantinescu A, Jiang L, Hahn EW, Mason RP. Prognostic radiology: quantitative assessment of tumor oxygen dynamics by MRI. Am J Clin Oncol. 2001 Oct; 24(5):462-6.
    View in: PubMed
    Score: 0.022
  26. Guo G, Gong K, Puliyappadamba VT, Panchani N, Pan E, Mukherjee B, Damanwalla Z, Bharia S, Hatanpaa KJ, Gerber DE, Mickey BE, Patel TR, Sarkaria JN, Zhao D, Burma S, Habib AA. Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastoma. Neuro Oncol. 2019 12 17; 21(12):1529-1539.
    View in: PubMed
    Score: 0.020
  27. Gong K, Guo G, Gerber DE, Gao B, Peyton M, Huang C, Minna JD, Hatanpaa KJ, Kernstine K, Cai L, Xie Y, Zhu H, Fattah FJ, Zhang S, Takahashi M, Mukherjee B, Burma S, Dowell J, Dao K, Papadimitrakopoulou VA, Olivas V, Bivona TG, Zhao D, Habib AA. TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer. J Clin Invest. 2018 06 01; 128(6):2500-2518.
    View in: PubMed
    Score: 0.018
  28. Bhatt NB, Pandya DN, Dezarn WA, Marini FC, Zhao D, Gmeiner WH, Triozzi PL, Wadas TJ. Practical Guidelines for Cerenkov Luminescence Imaging with Clinically Relevant Isotopes. Methods Mol Biol. 2018; 1790:197-208.
    View in: PubMed
    Score: 0.017
  29. Glowa C, Karger CP, Brons S, Zhao D, Mason RP, Huber PE, Debus J, Peschke P. Carbon ion radiotherapy decreases the impact of tumor heterogeneity on radiation response in experimental prostate tumors. Cancer Lett. 2016 08 10; 378(2):97-103.
    View in: PubMed
    Score: 0.015
  30. Wu Y, Hao G, Ramezani S, Saha D, Zhao D, Sun X, Sherry AD. [(68) Ga]-HP-DO3A-nitroimidazole: a promising agent for PET detection of tumor hypoxia. Contrast Media Mol Imaging. 2015 Nov-Dec; 10(6):465-72.
    View in: PubMed
    Score: 0.014
  31. Zhang Z, Yuan Q, Zhou H, Zhao D, Li L, Gerberich JL, Mason RP. Assessment of tumor response to oxygen challenge using quantitative diffusion MRI in an animal model. J Magn Reson Imaging. 2015 Nov; 42(5):1450-7.
    View in: PubMed
    Score: 0.014
  32. Hallac RR, Zhou H, Pidikiti R, Song K, Stojadinovic S, Zhao D, Solberg T, Peschke P, Mason RP. Correlations of noninvasive BOLD and TOLD MRI with pO2 and relevance to tumor radiation response. Magn Reson Med. 2014 May; 71(5):1863-73.
    View in: PubMed
    Score: 0.013
  33. Tumati V, Mathur S, Song K, Hsieh JT, Zhao D, Takahashi M, Dobin T, Gandee L, Solberg TD, Habib AA, Saha D. Development of a locally advanced orthotopic prostate tumor model in rats for assessment of combined modality therapy. Int J Oncol. 2013 May; 42(5):1613-9.
    View in: PubMed
    Score: 0.012
  34. Mason RP, Zhao D, Liu L, Trawick ML, Pinney KG. A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment. Integr Biol (Camb). 2011 Apr; 3(4):375-87.
    View in: PubMed
    Score: 0.011
  35. Mason RP, Zhao D, Pacheco-Torres J, Cui W, Kodibagkar VD, Gulaka PK, Hao G, Thorpe P, Hahn EW, Peschke P. Multimodality imaging of hypoxia in preclinical settings. Q J Nucl Med Mol Imaging. 2010 Jun; 54(3):259-80.
    View in: PubMed
    Score: 0.010
  36. Park S, Hatanpaa KJ, Xie Y, Mickey BE, Madden CJ, Raisanen JM, Ramnarain DB, Xiao G, Saha D, Boothman DA, Zhao D, Bachoo RM, Pieper RO, Habib AA. The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma. Cancer Res. 2009 Apr 01; 69(7):2809-16.
    View in: PubMed
    Score: 0.009
  37. Kwon CH, Zhao D, Chen J, Alcantara S, Li Y, Burns DK, Mason RP, Lee EY, Wu H, Parada LF. Pten haploinsufficiency accelerates formation of high-grade astrocytomas. Cancer Res. 2008 May 01; 68(9):3286-94.
    View in: PubMed
    Score: 0.009
  38. Jennewein M, Lewis MA, Zhao D, Tsyganov E, Slavine N, He J, Watkins L, Kodibagkar VD, O'Kelly S, Kulkarni P, Antich PP, Hermanne A, Rösch F, Mason RP, Thorpe PE. Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine. Clin Cancer Res. 2008 Mar 01; 14(5):1377-85.
    View in: PubMed
    Score: 0.009
  39. Bourke VA, Zhao D, Gilio J, Chang CH, Jiang L, Hahn EW, Mason RP. Correlation of radiation response with tumor oxygenation in the Dunning prostate R3327-AT1 tumor. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67(4):1179-86.
    View in: PubMed
    Score: 0.008
  40. Zhu Y, Guignard F, Zhao D, Liu L, Burns DK, Mason RP, Messing A, Parada LF. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell. 2005 Aug; 8(2):119-30.
    View in: PubMed
    Score: 0.007
  41. Jiang L, Zhao D, Constantinescu A, Mason RP. Comparison of BOLD contrast and Gd-DTPA dynamic contrast-enhanced imaging in rat prostate tumor. Magn Reson Med. 2004 May; 51(5):953-60.
    View in: PubMed
    Score: 0.007
  42. Kim JG, Zhao D, Song Y, Constantinescu A, Mason RP, Liu H. Interplay of tumor vascular oxygenation and tumor pO2 observed using near-infrared spectroscopy, an oxygen needle electrode, and 19F MR pO2 mapping. J Biomed Opt. 2003 Jan; 8(1):53-62.
    View in: PubMed
    Score: 0.006
  43. Mason RP, Hunjan S, Constantinescu A, Song Y, Zhao D, Hahn EW, Antich PP, Peschke P. Tumor oximetry: comparison of 19F MR EPI and electrodes. Adv Exp Med Biol. 2003; 530:19-27.
    View in: PubMed
    Score: 0.006
  44. Song Y, Worden KL, Jiang X, Zhao D, Constantinescu A, Liu H, Mason RP. Tumor oxygen dynamics: comparison of 19F MR EPI and frequency domain NIR spectroscopy. Adv Exp Med Biol. 2003; 530:225-36.
    View in: PubMed
    Score: 0.006
  45. Hunjan S, Zhao D, Constantinescu A, Hahn EW, Antich PP, Mason RP. Tumor oximetry: demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor. Int J Radiat Oncol Biol Phys. 2001 Mar 15; 49(4):1097-108.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.